About the job
About ByHeart
At ByHeart, we believe that infant nutrition should meet the highest standards. Our mission is to create formulas that closely mimic breast milk, ensuring optimal health outcomes for infants during their critical developmental stages. With a foundation built on cutting-edge nutritional science, we have pioneered advancements in infant formula over the past decade.
Our journey involved conducting the largest clinical trial for a new infant formula brand in 25 years, establishing our own manufacturing facilities, and formulating a groundbreaking product that incorporates a patented protein blend. This innovative formula includes the two most prevalent proteins found in breast milk—lactoferrin and alpha-lactalbumin—at levels that approach those found in nature, making it easier for infants to digest.
ByHeart’s commitment extends beyond product development; through our OpenHearted program, we have provided over 1,000,000 feeds to families in need. Following the 2023 formula shortage, we took bold steps to strengthen the U. S. supply chain by launching two new manufacturing sites, ensuring that every family has reliable access to high-quality, rigorously tested formula.
In light of a recent incident in November 2025, we have collaborated with the FDA and top experts to conduct a thorough audit of our production processes. Our findings have contributed to significant advancements in industry testing standards, helping to prevent future occurrences.
We are dedicated to maintaining our commitment to safety and transparency, ensuring that our priority is always the well-being of the families we serve.

